Diginex's October Deadline: A $1.05 Billion All-Paper Bet With a Balance Sheet Under Strain
Published on 08/26/2026 at 15:41 | Editorial boerse-global.de
The numbers tell a story of a company sprinting forward while bleeding from both sides. Diginex, the Hong Kong-rooted RegTech and blockchain firm, closed its fiscal year to March 31, 2026, with revenue up 77 percent to $3.6 million from $2.0 million a year earlier — growth fueled by the acquisitions of Plan A, Matter, and The Remedy Project. Yet the same period saw the net loss balloon to $31.1 million, with the adjusted EBITDA deficit more than doubling from $5.2 million to $13.0 million. A $7.0 million goodwill impairment on Matter sits at the heart of that deterioration, alongside $3.7 million in M&A costs and $5.6 million in stock-based compensation that pushed the operating loss to $24.9 million from $8.3 million.
An impairment of that size on a recently acquired subsidiary is more than a line-item footnote. It signals that not every deal is performing as planned — a cautionary detail for anyone tempted to read the topline growth as the full picture.
When a company's growth story is complicated by write-downs and restructuring, it's a reminder that the fundamentals behind any operation deserve scrutiny. The same applies to workplace safety — a gap in your risk assessments can surface as a costly problem later. A free toolkit with 41 ready-to-use templates and checklists helps you document hazards properly and stay compliant. Download the free Risk Assessment Toolkit
A Share Register About to Be Rewritten
The real story, however, is not the income statement but the transformation now underway. Diginex signed its acquisition agreement with Resulticks Global Companies roughly two weeks ago, and the terms are staggering for a firm with a market capitalization of barely €33 million. The consideration: 600 million new Diginex common shares at $1.75 each, valuing the all-paper deal at $1.05 billion. If completed, this will fundamentally alter the company's character, shifting it from a small-cap RegTech player into something far larger — and far more diluted.
To get there, Diginex has lined up $70 million in private financing commitments, with at least $20 million coming from Diginex itself and $50 million from Resulticks. The transaction carries a long-stop date that was already extended from July 31 to August 12, and management now targets closing by October 30, 2026. The combined entity's Nasdaq listing application under Rule 5110, plus other regulatory clearances, remain hard conditions rather than formalities.
Shareholders get their say on October 8 at an extraordinary general meeting, where the agenda covers not just the Resulticks acquisition but also an increase in authorized capital and charter amendments — all prerequisites for issuing such a massive block of shares. The record date for voting was set for August 14, with proxy materials expected to circulate around September 25.
The Price of Dilution
This is not a deal that crept up on the board. Diginex had already executed a reverse stock split at an 8-to-1 ratio in prior months, a mechanical adjustment that created headroom for the coming share issuance. For existing holders, the math is sobering: 600 million new shares at $1.75 each represents an extraordinary expansion of the register, and the dilution is the price of financing growth without taking on debt.
The company remains debt-free, but its cash position has thinned to $4.9 million. That explains the August capital raise of $20.0 million — 20.0 million new common shares plus five-year warrants exercisable at $1.00 — with proceeds expected to arrive between July 28, 2026, and March 31, 2027. It is a necessary measure to fund the next phase, though it compounds the dilution already baked into the Resulticks transaction.
Rhino Ventures now holds 40.1 percent of Diginex, based on 82.4 million outstanding common shares as of August 10, including 32.3 million shares from near-term exercisable warrants. That concentration cuts both ways: it signals a major investor's conviction while narrowing the free float and, with it, the influence of smaller shareholders.
Operational Moves Beneath the Surface
Amid the balance-sheet drama, Diginex has been quietly strengthening its bench. Jan-Jaap Verhoeve joined as chief commercial officer in July to accelerate global revenue growth, following the April appointments of Jacob Friedman as COO and Sandra Kovacheva as CAO. The management team is being built for a considerably larger enterprise.
There is also a compliance milestone worth noting: at the end of July, Diginex regained compliance with the Nasdaq minimum bid price requirement after closing at or above $1.00 for 20 consecutive trading days. That formal but important step keeps the listing intact ahead of the merger.
As Diginex works to satisfy Nasdaq's compliance standards, your own regulatory obligations deserve the same attention. UK employers face strict duties under the Health & Safety at Work Act 1974, and failing to document your compliance can expose you to significant liability. A free toolkit with 9 practical tools — including risk assessments and director liability guides — helps you meet those legal requirements without the guesswork. Get the free Health & Safety at Work Act 1974 Toolkit
The share price has moved just 1.5 percent since the Resulticks agreement was signed — hardly a vote of confidence, though the stock's 116 percent annualized volatility suggests the market is struggling to price a company that may not exist in its current form much longer. The real test comes on October 30, when the deal either closes or the narrative shifts. Between now and then, the progress of the Resulticks documentation and the shareholder vote on October 8 will matter far more than daily price action.
